CMCIX
Price
$28.25
Change
-$0.33 (-1.15%)
Updated
Sep 20 closing price
RPMGX
Price
$109.07
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

CMCIX vs RPMGX

Header iconCMCIX vs RPMGX Comparison
Open Charts CMCIX vs RPMGXBanner chart's image
Calvert Small/Mid-Cap I
Price$28.25
Change-$0.33 (-1.15%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth
Price$109.07
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CMCIX vs RPMGX Comparison Chart
Loading...
VS
CMCIX vs. RPMGX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMCIX is a StrongBuy and RPMGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 31.4B vs. CMCIX (65.1M). RPMGX pays higher dividends than CMCIX: RPMGX (0.05) vs CMCIX (0.00). CMCIX was incepted earlier than RPMGX: CMCIX (13 years) vs RPMGX (32 years). CMCIX is a more actively managed with annual turnover of: 43.00 vs. RPMGX (21.70). RPMGX has a lower initial minimum investment than CMCIX: RPMGX (2500) vs CMCIX (1000000). CMCIX annual gain was more profitable for investors over the last year : 20.19 vs. RPMGX (14.65). RPMGX (14.51) and CMCIX (14.46) have equivalent 5 years return.
CMCIXRPMGXCMCIX / RPMGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years32 years-
Gain YTD10.0509.026111%
Front LoadN/AN/A-
Min. Initial Investment1000000250040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets65.1M31.4B0%
Annual Yield % from dividends0.000.05-
Returns for 1 year20.1914.65138%
Returns for 3 years-5.05-13.8137%
Returns for 5 years14.4614.51100%
Returns for 10 years28.5743.2966%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CEAD6.90-0.10
-1.43%
CEA Industries
ELF112.91-1.68
-1.47%
elf Beauty
WAFD35.21-1.20
-3.30%
WaFd
PKST15.04-0.67
-4.26%
Peakstone Realty Trust
CHRS1.02-0.11
-9.73%
Coherus BioSciences